Chris Froome's Salbutamol Defence Boosted By Scientific Study

Chris Froome (Team Sky) waves at the start of stage 2

Chris Froome 's tilt at the Giro d’Italia didn't get off to the best start when he crashed during a recon of the opening time trial, but the battle to prove his innocence in his salbutamol case may have received a boost following the publication of a new scientific study. A research paper published last week in the British Journal of Clinical Pharmacology, and highlighted in an article on The Times website on Monday, has called the efficacy of the testing procedures for salbutamol into question. The paper, titled the 'Futility of current urine salbutamol doping control', concluded that it was not feasible to determine a dosage level based on the results of a single ‘untimed’ urine sample. Froome returned a salbutamol level of 2,000ng/ml in an anti-doping urine test conducted during the final week of last year’s Vuelta a España. The reading was twice the permitted level set out ...

Read on Cycling News


More Like This

Card image cap

What the newest salbutamol study means for Froome

View
Card image cap

Research paper raises questions about Salbutamol tests, may aid Froome’s defence

View
Card image cap

WADA will not appeal UCI verdict on Chris Froome salbutamol case

View
Card image cap

Analysis: WADA appears to contradict UCI over Froome case decision

View
Card image cap

UCI says no reasoned decision will be released for Froome case, elaborates on related topics

View
Card image cap

Opinion: Why WADA and the UCI’s handling of the Froome case is damaging to sport

View
Card image cap

Petacchi feels vindicated by resolution of Chris Froome case

View
Card image cap

Piss take: Researchers defend study claiming Salbutamol urine test is flawed

View
Card image cap

WADA defends salbutamol rules in wake of Froome acquittal

View
Card image cap

Chris Froome: Salbutamol tests need to be looked at to prevent false-positives

View